{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:29:14Z","timestamp":1790879354373,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The purpose of this study was to explore the clinical characteristics, survival time and prognostic factors of patients undergoing craniotomy for brain metastases (BM) from lung adenocarcinoma (LUAD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 208 patients with BM from LUAD who underwent craniotomy at the Zhengzhou University People\u2019s Hospital, Henan province, China from March 2005 to October 2022 were included in this retrospective study. All patients were confirmed as BM of LUAD by histopathology. The clinical data included patient gender, age, occupation, family history of tumor, smoking history, alcohol drinking history, neurological symptoms, history of lung cancer treatment, tumor location, tumor number, tumor size, gene status, expression of S-100, CEA, Ki67, and PD-L1 by immunohistochemistry, KPS after craniotomy, whether tumor therapy was continued after craniotomy, and survival time. Univariate and multivariate Cox regression was used to analyze the prognostic factors of patients undergoing craniotomy for LUAD BM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 208 patients met the inclusion and exclusion criteria, including 110 males (52.9%) and 98 females (47.1%), with an average age of 61.4 years. 203 patients (97.6%) had neurological symptoms. 84 patients (40.4%) had smoking history, 89 patients (42.8%) had alcohol drinking history, and 31 patients (14.9%) had the family history of tumor. Only 5 patients (2.4%) had received lung cancer treatment before craniotomy. The intracranial location of BM was mostly in the frontal lobe (54, 26.0%) and the metastatic sites were mostly single (117, 56.3%); the metastatic tumor size was mostly between 2-5\u00a0cm (141, 67.8%). Genetically, 43.3% patients (90 cases) had EGFR mutations, and immunohistochemical analysis showed that most patients were PD-L1 positive (160, 76.9%) and Ki67 &amp;gt; 30% (137, 65.9%). Most patients (145, 69.7%) had KPS score under 80 after craniotomy. Only 72 patients (34.7%) received continued tumor therapy after craniotomy. 190 patients (91.3%) were successfully followed up. The median survival time was 11.5 months, and the 3-year survival rate was 15.7%. Multivariate analysis revealed that smoking history, Ki67 percentage, KPS after craniotomy, and molecular targeted therapy after craniotomy were independent factors affecting the survival time of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although survival remains poor, patients who had no-smoking history, Ki67 percentage \u226430%, KPS\u226580 after craniotomy, and molecular targeted therapy after craniotomy can improve the prognosis and prolong the survival time.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1453177","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T08:38:05Z","timestamp":1737448685000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical characteristics and outcomes of surgical resection for brain metastases from lung adenocarcinoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Wakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.58","article-title":"The biology of brain metastases-translation to new therapies","volume":"8","author":"Eichler","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41568-019-0220-y","article-title":"Brain metastasis","volume":"20","author":"Boire","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1038\/s41467-022-33365-y","article-title":"The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002127","article-title":"Tumor microenvironment in lung cancer-derived brain metastasis","volume":"135","author":"Liu","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2356942","article-title":"HIF2A mediates lineage transition to aggressive phenotype of cancer-associated fibroblasts in lung cancer brain metastasis","volume":"13","author":"You","year":"2024","journal-title":"Oncoimmunology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11864-021-00911-7","article-title":"Systemic therapy for lung cancer brain metastases","volume":"22","author":"Pellerino","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14299","article-title":"Efficacy and safety of WBRT+EGFR-TKI versus WBRT only in the treatment of NSCLC patients with brain metastasis: An updated meta-analysis","volume":"13","author":"Zhou","year":"2022","journal-title":"Thorac Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000002372","article-title":"Extended survival in patients with non-small-cell lung cancer-associated brain metastases in the modern era","volume":"93","author":"Berger","year":"2023","journal-title":"Neurosurgery"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103054","article-title":"Stereotactic radiosurgery and immune checkpoint inhibitors in the management of brain metastases","volume":"19","author":"Lehrer","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.03.006","article-title":"Systemic treatment of brain metastases in non-small cell lung cancer","volume":"132","author":"Page","year":"2020","journal-title":"Eur J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2022.03.076","article-title":"Correlation of EGFR mutation subtypes and survival in surgically treated brain metastasis from non-small-cell lung cancer","volume":"46","author":"Perng","year":"2023","journal-title":"Asian J Surg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102620","article-title":"Research progress and challenges in the treatment of central nervous system metastasis of non-small cell lung cancer","volume":"10","author":"Wang","year":"2021","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41419-023-05823-y","article-title":"Identification of RAC1 in promoting brain metastasis of lung adenocarcinoma using single-cell transcriptome sequencing","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nox077","article-title":"Incidence and prognosis of patients with brain metastases at diagnosis of systemic Malignancy: a population-based study","volume":"19","author":"Cagney","year":"2017","journal-title":"Neuro Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12885-021-08490-4","article-title":"The incidence, risk factors and predictive nomograms for early death of lung cancer with synchronous brain metastasis: a retrospective study in the SEER database","volume":"21","author":"Shen","year":"2021","journal-title":"BMC Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2018.01.007","article-title":"Non-small-cell lung cancer with brain metastasis at presentation","volume":"19","author":"Waqar","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11060-022-04211-4","article-title":"Brain metastases from small cell lung cancer and non-small cell lung cancer: comparison of spatial distribution and identification of metastatic risk regions","volume":"161","author":"Shi","year":"2023","journal-title":"J Neurooncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205832","article-title":"Molecular epidemiology of smoking and lung cancer","volume":"21","author":"Shields","year":"2002","journal-title":"Oncogene"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0395","article-title":"Treatment of tobacco smoking: A review","volume":"327","author":"Rigotti","year":"2022","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07369-5","article-title":"Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial","volume":"359","author":"M\u00f8ller","year":"2002","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.089","article-title":"Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival","volume":"21","author":"Videtic","year":"2003","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.6.1784","article-title":"Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status","volume":"130","author":"Baser","year":"2006","journal-title":"Chest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2013.01.009","article-title":"Tobacco smoking: the leading cause of preventable disease worldwide","volume":"23","author":"Samet","year":"2013","journal-title":"Thorac Surg Clin"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1058","article-title":"The Effects of smoking status and smoking history on patients with brain metastases from lung cancer","volume":"6","author":"Shenker","year":"2017","journal-title":"Cancer Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-017-1774-3","article-title":"Ki67 targeted strategies for cancer therapy","volume":"20","author":"Yang","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-014-0639-8","article-title":"Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases","volume":"190","author":"Berghoff","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w","article-title":"The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting","volume":"53","author":"Mor","year":"1984","journal-title":"Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04293-8","article-title":"Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study","volume":"162","author":"Liang","year":"2023","journal-title":"J Neurooncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2014.25","article-title":"Current approaches to the treatment of metastatic brain tumours","volume":"11","author":"Owonikoko","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(93)90341-r","article-title":"CT characteristics of patients with brain metastases treated in RTOG study 79-16","volume":"25","author":"Swift","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2577","article-title":"Operative and peri-operative considerations in the management of brain metastasis","volume":"8","author":"Sankey","year":"2019","journal-title":"Cancer Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3171\/2023.11.JNS231923","article-title":"Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers","volume":"141","author":"Sauvageot","year":"2024","journal-title":"J Neurosurg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1023\/a:1021262218151","article-title":"Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease","volume":"61","author":"Pollock","year":"2003","journal-title":"J Neurooncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq076","article-title":"EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer","volume":"12","author":"Eichler","year":"2010","journal-title":"Neuro Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1468","article-title":"Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response","volume":"14","author":"Gow","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1453177\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T08:38:36Z","timestamp":1737448716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1453177\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":39,"alternative-id":["10.3389\/fonc.2024.1453177"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1453177","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"article-number":"1453177"}}